Trial · NCT04700423
Participant flow60
How many started, completed or left each group, period by period.
1 to 20 of 60
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Baseline/Treatment | STARTED | A: Moxidectin (8 mg) / Albendazole (400 mg) | 207 | |
| Baseline/Treatment | STARTED | B: Ivermectin (200 µg/kg) / Albendazole (400 mg) | 211 | |
| Baseline/Treatment | STARTED | C: Albendazole (400 mg) | 19 | |
| Baseline/Treatment | STARTED | D: Ivermectin (200 µg/kg) | 19 | |
| Baseline/Treatment | STARTED | E: Moxidectin (8 mg) | 80 | |
| Baseline/Treatment | COMPLETED | A: Moxidectin (8 mg) / Albendazole (400 mg) | 207 | |
| Baseline/Treatment | COMPLETED | B: Ivermectin (200 µg/kg) / Albendazole (400 mg) | 211 | |
| Baseline/Treatment | COMPLETED | C: Albendazole (400 mg) | 19 | |
| Baseline/Treatment | COMPLETED | D: Ivermectin (200 µg/kg) | 19 | |
| Baseline/Treatment | COMPLETED | E: Moxidectin (8 mg) | 80 | |
| Baseline/Treatment | NOT COMPLETED | A: Moxidectin (8 mg) / Albendazole (400 mg) | 0 | |
| Baseline/Treatment | NOT COMPLETED | B: Ivermectin (200 µg/kg) / Albendazole (400 mg) | 0 | |
| Baseline/Treatment | NOT COMPLETED | C: Albendazole (400 mg) | 0 | |
| Baseline/Treatment | NOT COMPLETED | D: Ivermectin (200 µg/kg) | 0 | |
| Baseline/Treatment | NOT COMPLETED | E: Moxidectin (8 mg) | 0 | |
| Follow-up 1: 14-21 Days Post Treatment | STARTED | A: Moxidectin (8 mg) / Albendazole (400 mg) | 207 | |
| Follow-up 1: 14-21 Days Post Treatment | STARTED | B: Ivermectin (200 µg/kg) / Albendazole (400 mg) | 211 | |
| Follow-up 1: 14-21 Days Post Treatment | STARTED | C: Albendazole (400 mg) | 19 | |
| Follow-up 1: 14-21 Days Post Treatment | STARTED | D: Ivermectin (200 µg/kg) | 19 | |
| Follow-up 1: 14-21 Days Post Treatment | STARTED | E: Moxidectin (8 mg) | 80 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04700423/flow